Systematic investigation of the genetic interactions that influence metastatic potential has been challenging. Here we developed massively parallel CRISPR-Cpf1/Cas12a crRNA array profiling (MCAP), an approach for combinatorial interrogation of double knockouts in vivo. We designed an MCAP library of 11,934 arrays targeting 325 pairwise combinations of genes implicated in metastasis. By assessing the metastatic potential of the double knockouts in mice, we unveiled a quantitative landscape of genetic interactions that drive metastasis.
Systematic investigation of the genetic interactions that influence metastatic potential has been challenging. Here we developed massively parallel CRISPR-Cpf1/Cas12a crRNA array profiling (MCAP), an approach for combinatorial interrogation of double knockouts in vivo. We designed an MCAP library of 11,934 arrays targeting 325 pairwise combinations of genes implicated in metastasis. By assessing the metastatic potential of the double knockouts in mice, we unveiled a quantitative landscape of genetic interactions that drive metastasis.
Metastasis, the major lethal factor of solid tumors, is a complex, multi-step process 1 . A systems-level understanding of the genetic interactions that influence metastatic potential is lacking, as libraryscale in vivo interrogation of double knockouts (DKOs) in mammalian species has proved challenging. The type V CRISPR system Cpf1 (also known as Cas12a) has empowered simultaneous genome editing at multiple loci [2] [3] [4] . Because Cpf1 does not require a transactivating CRISPR RNA (tracrRNA), multiplexed genome editing can be achieved with a single crRNA array 3, 4 . This characteristic inspired us to develop Cpf1 as a system for interrogating genetic interactions in vivo, with substantial advantages in library design, readout and analysis compared to Cas9-based approaches.
We first established a CRISPR-Cpf1 lentiviral system for characterization of double knockouts in a cancer cell line (KPD) 5, 6 (Supplementary Fig. 1 ). To evaluate the cellular diversity that can be accommodated in vivo, we cloned in a library of random 8-mers and transplanted 4 × 10 6 8-mer-barcoded cells into nu/nu (n = 2) or Rag1 −/− mice (n = 4). Of the 65,536 possible 8-mers, we recovered an average of 65,534.5 (99.99%) in nu/nu mice and 64,500.75 ± 940.58 (mean ± s.e.m.) (98.42%) in Rag1 −/− mice 12 d post-transplant ( Supplementary Fig. 2 ).
We then sought to develop MCAP, an approach for highthroughput screening of DKOs. We focused on genes significantly mutated in a human metastasis cohort (MET500) 7 and the top hits from a single-knockout (SKO) metastasis screen in mice 5 ( Fig. 1a and Supplementary Table 1) . We selected four CRISPR RNAs (crRNAs) for each of the 26 metastasis driver candidates. Compiling these 104 gene-targeting crRNAs and 52 non-targeting control (NTC) crRNAs, we designed a metastasis-focused MCAP library (MCAP-MET) composed of 1,326 NTC-NTC arrays, 5,408 SKO arrays and 5,200 DKO arrays, for a total of 11,934 dualcrRNA arrays (Supplementary Table 2 ). In the MCAP-MET library, each gene pair is represented by 16 DKO constructs and each gene is represented by 208 SKO constructs. Additionally, we appended a random 10-mer barcode for clonal analyses. Deep sequencing confirmed complete coverage of the library, and analysis of the 10-mer barcodes revealed the diversity of barcoded crRNA arrays (BC arrays) (n = 774,295) (Supplementary Fig. 3a-d) .
We generated lentiviral pools from the MCAP-MET plasmid library and infected Cpf1
+ KPD cells (Fig. 1b) . Seven and fourteen days after transduction, we sequenced the crRNAs in the cell pool, and found strong concordance with the plasmid library ( Supplementary Fig. 3e ). In each cell pool we recovered 172,427 ± 2,591 (mean ± s.e.m.) unique BC arrays. To map the metastatic potential of the MCAP-MET library, we injected the cell pool subcutaneously into nu/nu mice (4 × 10 6 cells per mouse, ×~350 coverage) (n = 10). At this coverage, each BC array is represented by an average of ~23 cells following injection. After 6 weeks we collected the primary tumors (n = 10) and lung lobes (n = 37), and performed crRNA array sequencing. Using the BC array data, we assessed the dynamics of selection in our metastasis model. We chose a 0.001% cutoff by considering the distribution of BC array frequencies in cell samples and quantified the number of 'clones' (approximated by BC arrays) per sample, finding clear evidence of progressive selection as the cell pools formed primary tumors and lung metastases ( Supplementary Fig. 4 ). These results were consistent at a frequency cutoff of ≥0.01% ( Supplementary Fig. 5 ). Collectively, the clonelevel analyses illustrate the progressive selection pressures on cells as they form primary tumors and metastasize to the lung.
We next considered the data in terms of the 11,934 dual-crRNA arrays ( Supplementary Fig. 6 and Supplementary Table 3) . Using the 1,326 NTC-NTC arrays as an empirical null distribution, we identified crRNA arrays enriched at a false discovery rate (FDR) < 0.5% in each sample ( Supplementary Fig. 7a ). We tabulated the percentage of arrays for a given genetic perturbation that were enriched in at least one sample ( Supplementary Fig. 7b,c) . No single genes had more than 40% of their SKO arrays enriched in lung metastases. In contrast, 62.5% of all arrays targeting the Nf2_Rb1 pair were enriched in at least one lung metastasis, with 56.25% of arrays enriched for Nf2_Pten and Nf2_Trim72 ( Supplementary Fig. 7d-f) .
We quantitatively determined the metastatic potential of the various perturbations represented in the MCAP-MET library ( Supplementary Fig. 8a-c) . To identify specific perturbations exhibiting strong selection in vivo, we averaged the crRNA arrays
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for each SKO or DKO condition on a sample-by-sample basis, then aggregated the data by sample type. To pinpoint the perturbations with the strongest selective advantage out of the entire MCAP-MET library, we used all targeting genes/pairs for linear regression modeling. The top gene pairs favored in primary tumors relative to cell pools (outlier test, adjusted P < 0.05) included Nf2_Trim72, Nf2_ Chd1, Nf2_Pten, Nf2_Arid1b, Nf2_Kdm6a and Nf2_Rb1 (Fig. 1c) . A similar set of gene pairs were enriched in lung metastases compared to cell pools ( Supplementary Fig. 8d ). Comparing primary tumors to lung metastases, Nf2_Trim72 and Nf2_Chd1 emerged as the top metastasis-driving mutation pairs (Fig. 1d) .
Our analyses suggested that certain gene pairs may be synergistic in promoting metastasis. To identify such mutation combinations, we first identified gene pairs that were significantly more abundant than their respective single gene counterparts (two-sided Wilcoxon rank sum test, adjusted P < 0.05). Because the effects of a mutation combination may simply be additive rather than synergistic, we calculated a synergistic coefficient (SynCo = DKO NM -SKO N -SKO M ) for each gene pair ( Fig. 2a and Supplementary Table 4) . Collectively, we found six DKOs that were significantly more abundant than the corresponding SKOs and with a SynCo > 0: Nf2_Trim72, Chd1_Nf2, Chd1_Kmt2d, Jak1_Kmt2c, Kmt2d_Pten and Nf1_Pten (Fig. 2b-d and Supplementary Fig. 9 ). These data were summarized as a librarywide map of the selective advantage of each DKO relative to the corresponding SKOs ( Supplementary Fig. 10 and Supplementary Table 5 ). Some of these synergistic interactions are recapitulated in human cohorts ( Supplementary Fig. 11 and Supplementary Table 6) .
We then sought to validate the metastatic potential of the strongest gene pair identified in the screen, Nf2_Trim72. After cloning in five different dual-crRNA arrays with combinations of Rosa26-targeting crRNAs or the top-performing Nf2 and Trim72 crRNAs from the screen (Rosa26 + Rosa26, Nf2 + Rosa26, Trim72 + Rosa26, Nf2 + Trim72 or Trim72 + Nf2), we assessed mutation efficiency 7 d after lentiviral transduction (n = 5 infection replicates each) and confirmed that array configuration did not influence mutation efficiency ( Fig. 3a and Supplementary Fig. 12a ). To exclude the possibility that the Nf2_Trim72 gene pair may have undergone positive selection in vitro before injection, we characterized the 5-ethynyl-2'-deoxyuridine (EdU) incorporation of KPD cells expressing Rosa26 + Rosa26, Nf2 + Rosa26, Trim72 + Rosa26 or Nf2 + Trim72 dual-crRNA arrays, and found no significant differences (n = 3 cell replicates each) ( Supplementary Fig. 12b,c) .
To interrogate the metastatic potential of the Nf2_Trim72 gene pair, we first performed in vitro Matrigel invasion assays (n = 3 independent experiments) and found that Nf2 + Trim72 infected cells were more invasive than Rosa26 + Rosa26, Nf2 + Rosa26 or Trim72 + Rosa26 infected cells ( Supplementary Fig. 12d,e) . We then proceeded to validate the Nf2_Trim72 gene pair in vivo, transplanting 1.8 × 10 6 cells into nu/nu mice (n = 8 mice for each condition). Primary tumors in the Nf2 + Trim72 group grew significantly larger than Nf2 + Rosa26, Trim72 + Rosa26 or Rosa26 + Rosa26 tumors (Fig. 3b) . We followed the development of metastasis by luciferase live imaging and, 28 d after the initial transplantation, we harvested the primary tumors and lungs ( Supplementary Fig. 13 ). Mice bearing Nf2 + Trim72 tumors had significantly more metastatic lung nodules than mice bearing Nf2 + Rosa26, Trim72 + Rosa26 or Rosa26 + Rosa26 tumors (Fig. 3c) . Collectively, these data point to specific mutation combinations with heightened metastatic potential in vivo, and highlight the power of MCAP for high-throughput interrogation of genetic interactions in challenging biological systems.
Several high-throughput double perturbations have been performed in mammalian cells using RNA interference or CRISPRCas9 technologies [8] [9] [10] [11] [12] [13] [14] [15] [16] . However, the dependence of Cas9 on a tracrRNA predicates the need for multiple single-guide RNA (sgRNA) cassettes for combinatorial knockouts, thus complicating library design, cloning, readout and analysis. In comparison, MCAP offers a streamlined approach for double or even higher-order knockout/perturbation screens, with the potential for sequential screens using invertible dual-crRNA arrays 17 . A remaining challenge that limits the broader utility of MCAP is the mutation efficiency of Cpf1, as this necessitates positive selection screens using redundant library designs with several independent constructs representing each perturbation. Of note, progress has been made toward predicting crRNAs that can induce mutations at higher efficiencies 18, 19 , and Cpf1 itself has been engineered to increase its activity and targeting range 20 . , respectively. Trim72 + Rosa26 versus Rosa26 + Rosa26, P = 0.0016. Statistical significance was assessed by two-sided unpaired Welch's t-test. NS, not significant; *P < 0.05, **P < 0.01, ***P < 0.001.
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The MCAP method can be readily applied to different cell types, biological processes and disease models and thus represents a tool for mapping genetic interactions in mammalian species in vivo with unparalleled simplicity and throughput.
online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41592-019-0371-5. Design of the MCAP-MET library. The top 23 annotated 'tumor suppressors' from the human MET500 cohort 7 were compiled, and combined with three top hits from a previous mouse metastasis screen (Nf2, Trim72 and Ube2g2) 5 for a final set of 26 genes. We then analyzed the complete exon sequences of these 26 genes to extract all possible Cpf1 spacers (that is, all 20-mers beginning with the Cpf1 protospacer-adjacent motif (PAM), 5′-TTTV). Each of these 20-mers was then reverse complemented and mapped to the entire mm10 reference genome by Bowtie 1.1.2 (ref. 22 ), with settings -n 2 -l 18 -p 8 -a -y --best -e 90. After filtering out all alignments that contained mismatches in the final three base pairs (corresponding to the Cpf1 PAM) and disregarding any mismatches in the fourth to last base pair, we quantified the number of genome-wide alignments for each crRNA using all 0, 1 and 2 mismatch (mm) alignments. A total mismatch score (MM score) was calculated for each crRNA using the following formula: MM score = 0 mm × 1,000 + 1 mm × 50 + 2 mm × 1. We also counted the number of consecutive thymidines in each crRNA, and used the following formula: T score = 100/(max_consecutive_Thymidines) (ref.
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2 ). We then sorted all 20-nt crRNAs corresponding to each target gene by low MM score and high T score. Finally, the top four crRNAs for each gene were chosen. In the event of ties, crRNAs targeting constitutive exons and/or the first exon were prioritized.
Fifty-two NTC crRNAs were randomly selected from a pool of random 20-mers that did not map to the mouse genome with up to two mismatches. In combination with the 104 crRNAs targeting 26 genes, a total of 5,200 DKO, 5,408 SKO and 1,326 NTC-NTC arrays was designed for a total of 11,934 dualcrRNA arrays (MCAP-MET library). With a total pool of 26 genes, the number of possible unique combinations of two different genes is 325. Each of these 325 gene pairs was represented by 16 DKO arrays, whereas each single gene condition was represented by 208 SKO arrays. For SKO crRNA arrays, we placed each genetargeting crRNA in the first position of the crRNA array and toggled the NTC crRNAs through the second position. For each gene pair, the positioning of the crRNAs representing each of the two genes was determined randomly. For each oligo, we appended a degenerate 10-mer (10 × N, where N denotes a random DNA nucleotide) following the U6 termination sequence to serve as a barcode for downstream clonality analysis. After pooled oligo synthesis (CustomArray), we used Gibson cloning to insert the MCAP-MET library into the BsmbI-linearized crRNA expression vector (pLenti-U6-DR-crRNA-Puro-P2A-Firefly luciferase).
Cell lines.
A non-small-cell lung cancer cell line 5, 6 (KPD cell line) was transduced with pLenti-EFs-Cpf1-Blast to generate Cpf1-positive cells (KPD-Cpf1). All cell lines were grown under standard conditions using DMEM containing 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (pen/strep) in a 5% CO 2 incubator. Lentiviral library production. Briefly, envelope plasmid pMD2.G, packaging plasmid psPAX2 and pLenti-MCAP-MET plasmid were added at a ratio of 1:1.5:2, and then polyethyleneimine was added and mixed well by vortexing. The solution was left at room temperature for 10-20 min, and then the mixture was added dropwise into 80-90% confluent HEK293FT cells and mixed well by gentle agitation of the plates. Six hours post-transfection, fresh DMEM supplemented with 10% FBS and 1% pen/strep was added to replace the transfection media. Virus-containing supernatant was collected at 48 and 72 h post-transfection, centrifuged at 1,500g for 10 min to remove the cell debris then aliquoted and stored at −80 °C. Virus was titrated by KPD cell infection at a number of different concentrations, followed by the addition of 3 μg ml -1 puromycin at 24 h postinfection to select the transduced cells. We determined viral titers by calculating the ratios of surviving cells 48 or 72 h post-infection and the cell count at infection. Nextera analysis of indels generated by Cpf1. crRNA arrays (crPten-crNf1 and crNf1-crPten) were cloned into the pLenti-U6-DR-crRNA-Puro vector, and virus was generated for transduction of KPD-Cpf1 cells.
Pten spacer = TGCATACGCTATAGCTGCTT Nf1 spacer = TAAGCATAATGATGATGCCA Six days after transduction and puromycin selection, genomic DNA was harvested from the cells in culture. The surrounding genomic regions flanking the target sites of crPten and crNf1 were first amplified by PCR using the following primers (5′-3′):
Using Phusion Flash High Fidelity Master Mix (Thermo Fisher), the thermocycling parameters for PCR were 98 °C for 2 min, 35 cycles of (98 °C for 1 s, 62 °C for 5 s, 72 °C for 15 s) and 72 °C for 2 min. Nextera XT library preparation was then performed according to the manufacturer's protocol with minor modifications. Reads were mapped to the mm10 mouse genome using BWA 23 , with the settings bwa mem -t 8 -w 200. Indel variants were first processed with Samtools 24 with the settings samtools mpileup -B -q 15 -d 10000000000000, then input into VarScan v.2.3.9 (ref. 25 ) with the settings pileup2indel --min-coverage 2 --min-reads2 2 --min-var-freq 0.00001. Variants occurring within ±7 nt of the predicted crRNA cut sites were summed to obtain total mutation frequencies.
Evaluation of in vivo library diversity in the absence of mutagenesis. We synthesized a library of degenerate 8-mers and cloned these into the crRNA expression vector. After lentiviral production, KPD cells were transduced with the 8-mer lentiviral library and selected by puromycin; 4 × 10 6 KPD-8-mer cells were subcutaneously injected in either Rag1
−/− or nu/nu mice. Twelve days after transplantation, mice were killed and tumors were isolated for genomic preparation and readout. Mouse tumor dissection. Mice were killed by carbon dioxide asphyxiation followed by cervical dislocation. Tumors and lungs were manually dissected, fixed in 10% formalin for 24-96 h and transferred into 70% ethanol. Tissues were flashfrozen with liquid nitrogen and ground in a 5-ml frosted polyethylene vial set (No. 2240-PEF) in a 2010 GenoGrinder machine (SPEXSamplePrep). Homogenized tissues were then used for DNA extraction.
Genomic DNA extraction. Frozen, ground tissue (200-800 mg) was resuspended in 6 ml of NK Lysis Buffer (50 mM Tris, 50 mM EDTA, 1% SDS, pH 8.0) supplemented with 30 μl of 20 mg ml -1 Proteinase K (Qiagen) in 15-ml conical tubes, and incubated in a bath at 55 °C overnight. After all the tissues were lysed, 30 μl of 10 mg ml -1 RNase A (Qiagen) was added, mixed well and incubated at 37 °C for 30 min. Samples were chilled on ice and then 2 ml of pre-chilled 7.5 M ammonium acetate (Sigma) was added to precipitate proteins. The samples were inverted and vortexed for 15-30 s and then centrifuged at ≥4,000g for 10 min. The supernatant was carefully decanted into a new 15-ml conical tube, followed by the addition of 6 ml of 100% isopropanol (at a ratio of ~0.7), inverted 30-50 times and centrifuged at ≥4,000g for 10 min. At this point, genomic DNA became visible as a small white pellet. After the supernatant had been discarded, 6 ml of freshly prepared 70% ethanol was added, mixed well and then centrifuged at ≥4,000g for 10 min. The supernatant was discarded by pouring, and remaining residue was removed using a pipette. After air-drying for 10-30 min, DNA was resuspended by the addition of 200-500 μl of nuclease-free H 2 O. Genomic DNA concentration was measured using a Nanodrop (Thermo Scientific) and normalized to 1,000 ng μl MCAP library readout. MCAP library readout was performed using a two-step PCR approach. Briefly, in the first round of PCR, sufficient genomic DNA was used as template to guarantee coverage of the library abundance and representation. Each sample contained 12 μg of genomic DNA, split between six separate PCR reactions. For the first PCR, the sgRNA-containing region was amplified using primers specific to the MCAP vector using Phusion Flash High Fidelity Master Mix (Thermo Fisher), with thermocycling parameters of 98 °C for 1 min, 15 cycles of (98 °C for 1 s, 60 °C for 5 s, 72 °C for 15 s) and 72 °C for 1 min.
Fwd: AATGGACTATCATATGCTTACCGTAACTTGAAAGTATTTCG Rev: CTTTAGTTTGTATGTCTGTTGCTATTATGTCTACTATTCTTTCCC In the second PCR, first-round PCR products for each biological replicate were pooled, then 2 μl of well-mixed first-round PCR products were used as the template for amplification, with sample-tracking barcode primers having thermocycling conditions set to 98 °C for 1 min, 15 cycles of (98 °C for 1 s, 60 °C for 5 s, 72 °C for 15 s) and 72 °C for 1 min. The second-round PCR products were quantified in 2%
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Nature Methods E-gel EX (Life Technologies) using E-Gel Low Range Quantitative DNA Ladder (Thermo Fisher), then the same amounts of each barcoded sample were combined. The pooled PCR products were purified using the QIAquick PCR Purification Kit and further QIAquick Gel Extraction Kit from 2% E-gel EX. The purified pooled library was quantified as above. Diluted libraries with 5-20% PhiX were sequenced with the HiSeq 4000 system (Illumina), with 150-bp paired-end read length.
MCAP-MET plasmid library readout and analysis.
Raw paired-end fastq read files were first merged to single fastq files by PEAR 26 with the settings -y 8 G -j 8 -v 3. The merged fastq files were then filtered and de-multiplexed using Cutadapt 27 , using two different sets of adaptors for extraction of crRNA array sequences or the 10-mer barcode. For the crRNA array, we used the following settings: cutadapt --discard-untrimmed -g tcttGTGGAAAGGACGAAACACCg, followed by cutadapt --discard-untrimmed -a TGTAGATTTTTTT. The trimmed sequences were then mapped to the MCAP-MET library using Bowtie 22 : bowtie -v 3 -k 1 -m 1. For the 10-mer barcodes, we used the following Cutadapt settings: cutadapt --discard-untrimmed -a aagcttggcgtGGATC, followed by cutadapt --discard-untrimmed -g TACTAAGTGTAGATTTTTTT. The resultant sequences were quantified to a reference of all possible 10-mer sequences. Reads that successfully mapped to the MCAP-MET library and contained a valid barcode were tabulated.
Processing of MCAP-MET crRNA array abundance in cells and tumors. PEARmerged
26 fastq files were filtered and de-multiplexed using Cutadapt 27 . To remove extra sequences downstream (3′ end) of the crRNA array sequences, including the DR and U6 terminator, we used the following settings: cutadapt --discarduntrimmed --e 0.1 -a aagcttggcgtGGATCCGATATCa -m 80. As the forward PCR primers used to read out crRNA array representation were designed to have a variety of barcodes to facilitate multiplexed sequencing, we then demultiplexed these filtered reads with the following settings: cutadapt -g file:fbc. fasta --no-trim, where fbc.fasta contained the 12 possible barcode sequences within the forward primers. Finally, to remove extraneous sequences upstream (5′ end) of the crRNA array spacers, we first used the following settings: cutadapt --discard-untrimmed --e 0.1 -g tcttGTGGAAAGGACGAAACACCg -m 80. Then, we removed the 5′ DR as follows: cutadapt --discarduntrimmed -e 0.1 -g TAATTTCTACTAAGTGTAGAT -m 80. The filtered fastq reads were then mapped to the MCAP-MET reference index. To do so, we first generated a Bowtie index of the MCAP-MET library using the bowtie-build command in Bowtie 1.1.2 (ref. 22 ). Using these bowtie indexes, we mapped the filtered fastq read files using the following settings: bowtie -n 2 -k 1 -m 1 --best. These settings ensured that only single-match reads would be retained for downstream analysis. For data processing on the level of barcoded crRNAs, we used the same trimmed fastq files as above but instead employed the barcoded crRNA plasmid library as the reference index.
Analysis of MCAP crRNA array library representation. Using the resultant mapping output, we quantified the number of reads that had mapped to each crRNA array within the library. We normalized the number of reads in each sample by converting raw crRNA array counts to reads per million (RPM). The RPM values were then subjected to log 2 transformation for certain analyses. Where applicable, linear regression lines and 95% confidence intervals were calculated. For comparison of cells, primary tumors and lung metastases, crRNA array abundances were averaged within sample groups and linear regression was performed using the NTC-NTC arrays as a model for neutral selection. Significant outliers were identified using the outlierTest function from the 'car' R package, which calculates the studentized residuals of the linear regression and derives the corresponding P values. The Benjamini-Hochberg procedure was then used to adjust P values for multiple comparisons. For gene/gene pair analyses, the corresponding SKO and DKO arrays were first averaged together, then aggregated by sample type. Linear regression was performed using all SKO/DKO genotypes, and outliers were identified as above.
Clone-level analysis of MCAP-MET samples. We analyzed the data at the clone level using the barcoded crRNA abundances. We first converted the counts in each sample to percentages of total reads. We then used two different frequency cutoffs for considering 0.01% and ≥0.001%. Differences in the number of clones between sample types were assessed by two-sided Wilcoxon rank sum test, and visualized after log 2 transform. Empirical cumulative distribution function was calculated after combining all the clones in a given sample group; statistical differences in clone size distributions were assessed by two-sided Kolmogorov-Smirnov test. The Shannon diversity index was also calculated on each sample with the 'vegan' R package; statistical differences were assessed by two-sided Wilcoxon rank sum test.
Enrichment analysis of MCAP-MET genotypes.
To identify crRNA arrays that were enriched in individual samples, we used the 1,326 NTC-NTC arrays for modeling the empirical null distribution. Enriched crRNA arrays were subsequently called at FDR < 0.5%. These results were aggregated to the single gene/gene pair level, then tabulated across samples. Finally, we counted all significant crRNA arrays associated with each genotype.
Identification of synergistic mutation combinations. We defined the SynCo score for each gene pair with the following formula: SynCo = DKO NM -SKO N -SKO M . The DKO NM value is the median log 2 RPM abundance of all corresponding DKO crRNA arrays (that is, crN-crM), whereas SKO N and SKO M values are defined as the median log 2 RPM abundance of all corresponding SKO crRNA arrays. We calculated the SynCo of each gene pair within the lung metastasis samples and further assessed whether the DKO abundances were statistically significantly higher than the corresponding SKO abundances, by two-sided Wilcoxon rank sum test. We defined synergistic mutation combinations as gene pairs where (1) the SynCo score was >0 and (2) the median differential abundances compared to the corresponding SKOs were both >0.2, with an associated Benjamini-Hochberg adjusted P < 0.05 for both comparisons. To generate a library-wide map of the relative selective advantages for each gene pair versus single gene knockout, we used the aggregated gene-level abundances in lung metastasis samples. We compared the abundance of each DKO to its reference SKO, and visualized the data in a heat map. Each column refers to the reference SKO, whereas each row denotes the modulatory effects of the second KO.
Design of dual-crRNA arrays for validation experiments. Dual-crRNA arrays containing combinations of Rosa26-targeting crRNAs or the best-performing Nf2 and Trim72 crRNA were designed. The following spacer sequences were used: crRosa26.1: AGGCTATATTTCTGCTGTCT crRosa26.2: TAGTTCAAAGCTTCTGACAG crNf2: AAGGCCTCGATCTCCGTCTT crTrim72: TGCCGTGCCTGCCTGATCCG Insertion of NLS-green fluorescent protein (GFP) sequences into the crRNA expression vector. The primary screen experiments were performed using the U6 crRNA expression vector with an EF1-α short (EFS) promoter driving expression of puromycin and firefly luciferase. For validation experiments, the coding sequences for NLS-EGFP were inserted after puromycin-P2A-luciferase in the crRNA expression vector by Gibson cloning, with a P2A sequence separating the GFP.
Quantification of mutation frequency by T7E1. Seven days after lentiviral transduction and puromycin selection, genomic DNA was extracted from the cells. PCR amplification of the genomic regions flanking the Nf2 or Trim72 crRNAs was performed using the following primers:
Nf2_F: CTCCTGAGGAAACTAGATGCCAACCT Nf2_R: AAAGCTGTCTGTGGCAGGGTTATTTG Trim72_F: GAGGAGAGGGCTGGGTATTTGAGAGA Trim72_R: GCTGCCAAGCAAGGTAGGTAGCTATT Using Phusion Flash High Fidelity Master Mix (Thermo Fisher), the thermocycling parameters for PCR were 98 °C for 2 min, 35 cycles of (98 °C for 1 s, 60 °C for 5 s, 72 °C for 15 s) and 72 °C for 2 min.
The PCR amplicons were then used for T7E1 assays according to the manufacturer's protocol. Statistical significance was assessed by two-sided unpaired Welch's t-test.
EdU proliferation assay.
To assess proliferation, we used the Click-iT EdU Alexa Fluor 647 Flow Cytometry Assay Kit (Thermo Fisher, No. C10419). Cells underwent incubation in culture with 10 μM EdU solution for 2 h, followed by fixation, permeabilization and staining. Cells were then analyzed on a BD FACSAria and the data were processed using FlowJo. Statistical significance was assessed by two-sided unpaired Welch's t-test.
Matrigel invasion assay.
For in vitro assessment of invasive potential, unsupplemented DMEM was first mixed with standard Matrigel (Corning, No. 356234) on ice using pre-chilled pipette tips to a final concentration of 25% Matrigel. After placing FluoroBlok cell culture inserts with 8-μm pores into a 24-well plate, we added 100 μl of the 25% Matrigel to each insert. The inserts were incubated in the cell culture incubator for 1 h to solidify the Matrigel. Cultured cells were then resuspended in unsupplemented DMEM at a concentration of 0.5 × 10 6 cells ml -1 , and 200 μl of the cell suspension was gently added on top of the Matrigel layer. Finally, 600 μl of 10% FBS DMEM was added to each well, underneath the inserts. Invasive cells were quantified using an inverted microscope 24 h later on the GFP channel. Statistical significance was assessed by two-sided unpaired Welch's t-test.
Luciferase imaging for tracking metastasis. Mice were anesthetized by isoflurane inhalation and imaged for metastasis using an IVIS machine (PerkinElmer) for 5 min following intraperitoneal injection of firefly d-luciferin potassium salt (150 mg kg -1 body weight).
Quantification of primary tumors and lung metastases. Mice were anesthetized by isoflurane inhalation, and tumor sizes were quantified
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Nature Methods every 2-3 d by calipers, using the formula volume (mm 3 ) = π (6 × x × y × z) -1 . Statistical significance was assessed by two-way ANOVA, jointly considering the effect of time and treatment condition. Mice were killed at 28 d post-infection, and lungs were harvested for quantification of lung metastases. Each lung lobe was separately visualized under a dissecting microscope. Lung lobe metastases were quantified on bright-field images with real-time confirmation by GFP expression. Statistical significance was assessed by twosided unpaired Welch's t-test.
Genomic comparisons of human primary tumors and metastases. Mutation frequencies from the TCGA PanCancer dataset and the MET500 dataset were filtered for the 26 genes represented in the MCAP-MET library. We determined the statistical significance of Spearman correlation by calculating the t-statistic of the correlation. Identification of gene pairs that were significantly co-mutated was determined by hypergeometric test.
Statistics. All statistical tests are unpaired and two-sided. Details about the statistical tests are described in the corresponding figure legends and Methods subsections. The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Software and code
Policy information about availability of computer code
Data collection
No software or code was used for data collection.
Data analysis
Nextera genomic sequencing reads were mapped to the mm10 mouse genome using BWA, with the settings bwa mem -t 8 -w 200. Indel variants were first processed with Samtools with the settings samtools mpileup -B -q 15 -d 10000000000000, then input into VarScan v2.3.9 with the settings pileup2indel --min-coverage 2 --min-reads2 2 --min-var-freq 0.00001. Variants occurring within a ± 7nt window of the predicted crRNA cut sites were summed to obtain total mutation frequencies.
For MCAP plasmid library readout analysis, raw paired-end fastq read files were first merged to single fastq files by PEAR with the settings -y 8G -j 8 -v 3. The merged fastq files were then filtered and demultiplexed using Cutadapt, using two different sets of adapters for extraction of crRNA array sequences or the 10mer barcode. For the crRNA array, we used the following settings: cutadapt --discarduntrimmed -g tcttGTGGAAAGGACGAAACACCg, followed by cutadapt --discard-untrimmed -a TGTAGATTTTTTT. The trimmed sequences were then mapped to the MCAP-MET library using Bowtie v1.1.2: bowtie -v 3 -k 1 -m 1. For the 10mer barcodes, we used the following Cutadapt settings: cutadapt --discard-untrimmed -a aagcttggcgtGGATC, followed by cutadapt --discard-untrimmed -g TACTAAGTGTAGATTTTTTT. The resultant sequences were quantified to a reference of all possible 10mer sequences. Reads that successfully mapped to both the MCAP-MET library and contained a valid barcode were tabulated.
For analyzing MCAP library readout from cells and tumors, PEAR-merged fastq files were filtered and demultiplexed using Cutadapt. To remove extra sequences downstream (i.e. 3' end) of the crRNA array sequences, including the DR and U6 terminator, we used the following settings: cutadapt --discard-untrimmed -e 0.1 -a aagcttggcgtGGATCCGATATCa -m 80. As the forward PCR primers used to
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readout crRNA array representation were designed to have a variety of barcodes to facilitate multiplexed sequencing, we then demultiplexed these filtered reads with the following settings: cutadapt -g file:fbc.fasta --no-trim, where fbc.fasta contained the 12 possible barcode sequences within the forward primers. Finally, to remove extraneous sequences upstream (i.e. 5' end) of the crRNA array spacers, we first used the following settings: cutadapt --discard-untrimmed -e 0.1 -g tcttGTGGAAAGGACGAAACACCg -m 80. Then, we removed the 5' DR as follows: cutadapt --discard-untrimmed -e 0.1 -g TAATTTCTACTAAGTGTAGAT -m 80. The filtered fastq reads were then mapped to the MCAP-MET reference index. To do so, we first generated a Bowtie index of the MCAP-MET library using the bowtie-build command in Bowtie 1.1.2. Using these bowtie indexes, we mapped the filtered fastq read files using the following settings: bowtie -n 2 -k 1 -m 1 --best. These settings ensured only single-match reads would be retained for downstream analysis. For data processing on the level of barcoded-crRNAs, we utilized the same trimmed fastq files as above, but instead used the barcoded-crRNA plasmid library as the reference index.
Using the resultant mapping output, we quantified the number of reads that had mapped to each crRNA array within the library. We normalized the number of reads in each sample by converting raw crRNA array counts to reads per million (rpm). The rpm values were then subject to log-2 transformation for certain analyses. Where applicable, linear regression lines and 95% confidence intervals were calculated. For comparing cells, primary tumors, and lung metastases, crRNA array abundances were averaged within sample groups and linear regression was performed using the NTC-NTC arrays as a model for neutral selection. Significant outliers were identified using the outlierTest function from the car R package, which calculates the studentized residuals of the linear regression and derives the corresponding p-values. The Benjamini-Hochberg procedure was then used to adjust p-values for multiple comparisons. For gene/gene pair analyses, the corresponding SKO and DKO arrays were first averaged together, then aggregated by sample type. Linear regression was performed using all SKO/DKO genotypes, and outliers were identified as above.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability MCAP data, sequences of oligos, and library design are described in the Methods section and Supplementary Tables. All vectors and libraries have been deposited to  Addgene (#123359, #123360 , #123361, #123362, and #123363) and are available to the academic community. Cell lines and all data supporting this work will be available to the academic community upon request. Genomic sequencing data has been deposited to NCBI SRA (PRJNA515306).
Field-specific reporting Life sciences study design All studies must disclose on these points even when the disclosure is negative.
Sample size
No specific methods were used to predetermine sample sizes. Sample sizes were chosen based on experience from our prior published work (Chen et al., Cell 2015) .
Data exclusions No data were excluded.
Replication
All experiments were performed using multiple entirely biologically independent replicates, and replication efforts were successful.
Randomization Animals were randomly allocated to different experimental groups.
Blinding
Investigators were not blinded for experiments or analysis. All experimental conditions were carefully controlled and done in parallel, consistent with our established protocols. Multiple independent investigators were involved at all stages of each experiment to ensure accountability and proper experimental practices.
Reporting for specific materials, systems and methods No commonly misidentified cell lines were used in this study, as defined by the ICLAC register.
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research Laboratory animals 6-8 week old, both male and female, nu/nu mice or Rag1-/-mice were used for experiments. Only 6-8 week old female nu/nu mice were used in validation experiments.
Wild animals
The study did not involve the use of wild animals.
Field-collected samples
The study did not involve the use of field-collected samples.
Flow Cytometry Plots
Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology Sample preparation
To assess proliferation, we used the Click-iT EdU Alexa Fluor 647 Flow Cytometry Assay Kit (ThermoFisher, #C10419). We incubated cells in culture with 10 μM for 2 hours, followed by fixation, permeabilization, and staining. Cells were then analyzed on a BD FACSAria and the data was processed using FlowJo. Statistical significance was assessed by two-sided unpaired Welch's t-test.
Instrument BD FACSAria
Software FlowJo Cell population abundance Gating was done on live single cells (>75% for all samples).
Gating strategy
See Supplementary Figure 12b for gating strategy.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
